Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Regenerative Medical Technology (RMTG) Cost of Revenue (2018 - 2025)

Historic Cost of Revenue for Regenerative Medical Technology (RMTG) over the last 8 years, with Q3 2025 value amounting to $678977.0.

  • Regenerative Medical Technology's Cost of Revenue rose 18379.75% to $678977.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year increase of 11697.54%. This contributed to the annual value of $1.3 million for FY2024, which is 7491.51% up from last year.
  • Per Regenerative Medical Technology's latest filing, its Cost of Revenue stood at $678977.0 for Q3 2025, which was up 18379.75% from $397686.0 recorded in Q2 2025.
  • In the past 5 years, Regenerative Medical Technology's Cost of Revenue ranged from a high of $678977.0 in Q3 2025 and a low of $11860.0 during Q2 2021
  • Its 5-year average for Cost of Revenue is $234567.2, with a median of $196535.0 in 2023.
  • Examining YoY changes over the last 5 years, Regenerative Medical Technology's Cost of Revenue showed a top increase of 677295.9% in 2021 and a maximum decrease of 3726.2% in 2021.
  • Over the past 5 years, Regenerative Medical Technology's Cost of Revenue (Quarter) stood at $172580.0 in 2021, then rose by 20.2% to $207442.0 in 2022, then decreased by 12.83% to $180818.0 in 2023, then soared by 193.47% to $530640.0 in 2024, then rose by 27.95% to $678977.0 in 2025.
  • Its Cost of Revenue was $678977.0 in Q3 2025, compared to $397686.0 in Q2 2025 and $420447.0 in Q1 2025.